Monopar
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
All edits
Edits on 24 May, 2023
Golden AI
Edits on 6 Apr, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 5 Sep, 2022
Petrushkevych Anastasiia
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Petrushkevych Anastasiia
Edits made to:
Infobox (+1 properties)
Infobox
Petrushkevych Anastasiia
Edits made to:
Infobox (+1 properties)
Infobox
Pitchbook URL
Edits on 13 Jul, 2022
Bhupendra Solanki
Edits made to:
Infobox (+1 properties)
Infobox
Company Operating Status
Active
Edits on 12 Jun, 2022
Golden AI
Edits on 6 Apr, 2022
Andrey Duzenko
Edits made to:
Infobox (+4 properties)
Infobox
Edits on 17 Feb, 2022
Mevludin Mešanović
Edits made to:
Monopar
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
Edits on 16 Feb, 2022
Keeri Tramm
Edits made to:
Infobox (+4 properties)
Description (+110 characters)
Monopar
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
Infobox
Edits on 17 Aug, 2021
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Latest funding round date
November 14, 2017
Total funding amount (USD)
9,700,000
Golden AI
Golden AI
Edits made to:
Infobox (+3 properties)
Monopar
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
Infobox
Find more companies like Monopar
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.